Many celebrities have undergone dramatic weight loss, avoiding using ozmpic despite its increasing popularity.

While many western stars openly admitted to using the drug, others remain silent, speculating about its role in their changes.

Addressing this reluctance, Vikrant Shrotriya, Corporate Vice President and Managing Director of Novo Nordisk India, said, “They just want to pat their backs that they have a great gene. But losing weight is never easy, and it is never easy to achieve it.

The ozemic is a prescription drug, developed by Global Pharma company Novo Nordisk, which helps to control blood sugar levels for people with type 2 diabetes. It is a self-prasaded injection under the skin once a week.

The drug is a glucagon -like peptide -1 (GLP -1) receptor agonist, which comes in 0.5 mg, 1 mg or 2 mg doses. This class of drugs mimics GLP-1 hormone that helps control insulin (hormone) secretions and appetite. By slowing down digestion, it reduces signs of appetite in the brain.

During today’s session in India, in 2025, he said that ozmpic is a long -term drug for any metabolic disease, in which one loses weight.

He said that ozmpic is a long -term drug for any metabolic disease, in which one loses weight.

Addressing concerns about reports of serious side effects of the ozemic, Vikrant said that the drug has passed through a rigorous evaluation process.

“It is important to understand how a drug reaches the market. It undergoes rigorous evaluation through phase 1, step 2, and step 3 tests to assess its safety and effectiveness. Ozmpic has been fully studied for its risks and benefits. A drug is approved only when benefited from benefits,” Wikranant explained.

He said, “We have a security monitoring through regular audit reports. After the launch it was launched, we were surprised because there was much more demand than what we demand.”

He also said that some patients may require a supplementary as well as supplements.

“Not all patients are the same. Some may lack B-complex and require supplements, while others may have osteoporosis. Obesity rarely is present in isolation, often with other comorid conditions. About 50% of obesity also have high blood pressure, and many may have osteogenesis or diabetics.

Given Comorbidities, ozepic is never a standalone solution. “In some cases, nutrition dose may be necessary as part of the treatment plan,” he said.

Ozmpic is a prescription drug that helps control blood sugar levels for people with type 2 diabetes. It belongs to the GLP -1 square of drugs, which controls a person’s appetite and helps to control insulin (hormone) secretion. By slowing down digestion, it reduces signs of appetite in the brain.

It is being constructed and distributed worldwide, which is yet to be approved in India.